Try our beta test site
1 study found for:    16406806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Conditions: Multiple Sclerosis (MS);   Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone;   Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM);   Procedure: Autologous hematopoietic stem cell transplant

Study has passed its completion date and status has not been verified in more than two years.